| Health / Medical Topics |
NY-ESO-1 Plasmid DNA Cancer Vaccine
A plasmid DNA encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1 with potential immunostimulating and antitumor activities. Upon administration, NY-ESO-1 plasmid DNA cancer vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing the NY-ESO-1 antigen, resulting in tumor cell lysis. NY-ESO-1 is a tumor associated antigen (TAA) found in normal testes and expressed on the surfaces of various tumor cells, including melanoma, breast, bladder, prostate, lung, ovarian, and hepatocellular tumor cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various…
A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.
A regimen consisting of vincristine, doxorubicin, etoposide alternating with cyclophosphamide and etoposide, administered with radiation therapy and used for the treatment of…
A genetically engineered oncolytic virus with potential antineoplastic property. NV1020 is constructed from the herpes simplex virus 1 (HSV-1) by the deletion…
An herbal remedy derived from the seeds of the evergreen tree Strychnos nux-vomica, a native to southeast Asia and northern Australia. The…
A drug that is used to treat certain sleep disorders, such as narcolepsy. It makes patients feel more alert and…
